Copyright Reports & Markets. All rights reserved.

Global Stem Cell Therapy for Osteoarthritis Supply, Demand and Key Producers, 2026-2032

Request for Sample of this report
Buy now

1 Supply Summary

  • 1.1 Stem Cell Therapy for Osteoarthritis Introduction
  • 1.2 World Stem Cell Therapy for Osteoarthritis Market Size & Forecast (2021 & 2025 & 2032)
  • 1.3 World Stem Cell Therapy for Osteoarthritis Total Market by Region (by Headquarter Location)
    • 1.3.1 World Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2032), (by Headquarter Location)
    • 1.3.2 United States Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.3 China Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.4 Europe Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.5 Japan Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.6 South Korea Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.7 ASEAN Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
    • 1.3.8 India Based Company Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Stem Cell Therapy for Osteoarthritis Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Major Market Trends

2 Demand Summary

  • 2.1 World Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.2 World Stem Cell Therapy for Osteoarthritis Consumption Value by Region
    • 2.2.1 World Stem Cell Therapy for Osteoarthritis Consumption Value by Region (2021-2026)
    • 2.2.2 World Stem Cell Therapy for Osteoarthritis Consumption Value Forecast by Region (2027-2032)
  • 2.3 United States Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.4 China Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.5 Europe Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.6 Japan Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.7 South Korea Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.8 ASEAN Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)
  • 2.9 India Stem Cell Therapy for Osteoarthritis Consumption Value (2021-2032)

3 World Stem Cell Therapy for Osteoarthritis Companies Competitive Analysis

  • 3.1 World Stem Cell Therapy for Osteoarthritis Revenue by Player (2021-2026)
  • 3.2 Industry Rank and Concentration Rate (CR)
    • 3.2.1 Global Stem Cell Therapy for Osteoarthritis Industry Rank of Major Players
    • 3.2.2 Global Concentration Ratios (CR4) for Stem Cell Therapy for Osteoarthritis in 2025
    • 3.2.3 Global Concentration Ratios (CR8) for Stem Cell Therapy for Osteoarthritis in 2025
  • 3.3 Stem Cell Therapy for Osteoarthritis Company Evaluation Quadrant
  • 3.4 Stem Cell Therapy for Osteoarthritis Market: Overall Company Footprint Analysis
    • 3.4.1 Stem Cell Therapy for Osteoarthritis Market: Region Footprint
    • 3.4.2 Stem Cell Therapy for Osteoarthritis Market: Company Product Type Footprint
    • 3.4.3 Stem Cell Therapy for Osteoarthritis Market: Company Product Application Footprint
  • 3.5 Competitive Environment
    • 3.5.1 Historical Structure of the Industry
    • 3.5.2 Barriers of Market Entry
    • 3.5.3 Factors of Competition
  • 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

  • 4.1 United States VS China: Stem Cell Therapy for Osteoarthritis Revenue Comparison (by Headquarter Location)
    • 4.1.1 United States VS China: Stem Cell Therapy for Osteoarthritis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
    • 4.1.2 United States VS China: Stem Cell Therapy for Osteoarthritis Revenue Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States Based Companies VS China Based Companies: Stem Cell Therapy for Osteoarthritis Consumption Value Comparison
    • 4.2.1 United States VS China: Stem Cell Therapy for Osteoarthritis Consumption Value Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Stem Cell Therapy for Osteoarthritis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States Based Stem Cell Therapy for Osteoarthritis Companies and Market Share, 2021-2026
    • 4.3.1 United States Based Stem Cell Therapy for Osteoarthritis Companies, Headquarters (States, Country)
    • 4.3.2 United States Based Companies Stem Cell Therapy for Osteoarthritis Revenue, (2021-2026)
  • 4.4 China Based Companies Stem Cell Therapy for Osteoarthritis Revenue and Market Share, 2021-2026
    • 4.4.1 China Based Stem Cell Therapy for Osteoarthritis Companies, Company Headquarters (Province, Country)
    • 4.4.2 China Based Companies Stem Cell Therapy for Osteoarthritis Revenue, (2021-2026)
  • 4.5 Rest of World Based Stem Cell Therapy for Osteoarthritis Companies and Market Share, 2021-2026
    • 4.5.1 Rest of World Based Stem Cell Therapy for Osteoarthritis Companies, Headquarters (Province, Country)
    • 4.5.2 Rest of World Based Companies Stem Cell Therapy for Osteoarthritis Revenue (2021-2026)

5 Market Analysis by Type

  • 5.1 World Stem Cell Therapy for Osteoarthritis Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Fat Cell
    • 5.2.2 Bone Marrow Cell
    • 5.2.3 Others
  • 5.3 Market Segment by Type
    • 5.3.1 World Stem Cell Therapy for Osteoarthritis Market Size by Type (2021-2026)
    • 5.3.2 World Stem Cell Therapy for Osteoarthritis Market Size by Type (2027-2032)
    • 5.3.3 World Stem Cell Therapy for Osteoarthritis Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

  • 6.1 World Stem Cell Therapy for Osteoarthritis Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Primary Osteoarthritis
    • 6.2.2 Secondary Osteoarthritis
  • 6.3 Market Segment by Application
    • 6.3.1 World Stem Cell Therapy for Osteoarthritis Market Size by Application (2021-2026)
    • 6.3.2 World Stem Cell Therapy for Osteoarthritis Market Size by Application (2027-2032)
    • 6.3.3 World Stem Cell Therapy for Osteoarthritis Market Size Market Share by Application (2021-2032)

7 Company Profiles

  • 7.1 Medipost
    • 7.1.1 Medipost Details
    • 7.1.2 Medipost Major Business
    • 7.1.3 Medipost Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.1.4 Medipost Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Medipost Recent Developments/Updates
    • 7.1.6 Medipost Competitive Strengths & Weaknesses
  • 7.2 Theracell Advanced Biotechnology
    • 7.2.1 Theracell Advanced Biotechnology Details
    • 7.2.2 Theracell Advanced Biotechnology Major Business
    • 7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.2.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Theracell Advanced Biotechnology Recent Developments/Updates
    • 7.2.6 Theracell Advanced Biotechnology Competitive Strengths & Weaknesses
  • 7.3 Nature Cell
    • 7.3.1 Nature Cell Details
    • 7.3.2 Nature Cell Major Business
    • 7.3.3 Nature Cell Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.3.4 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Nature Cell Recent Developments/Updates
    • 7.3.6 Nature Cell Competitive Strengths & Weaknesses
  • 7.4 Stempeutics
    • 7.4.1 Stempeutics Details
    • 7.4.2 Stempeutics Major Business
    • 7.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.4.4 Stempeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Stempeutics Recent Developments/Updates
    • 7.4.6 Stempeutics Competitive Strengths & Weaknesses
  • 7.5 Regeneus
    • 7.5.1 Regeneus Details
    • 7.5.2 Regeneus Major Business
    • 7.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.5.4 Regeneus Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Regeneus Recent Developments/Updates
    • 7.5.6 Regeneus Competitive Strengths & Weaknesses
  • 7.6 Xintela AB
    • 7.6.1 Xintela AB Details
    • 7.6.2 Xintela AB Major Business
    • 7.6.3 Xintela AB Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.6.4 Xintela AB Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Xintela AB Recent Developments/Updates
    • 7.6.6 Xintela AB Competitive Strengths & Weaknesses
  • 7.7 Cells for Cells
    • 7.7.1 Cells for Cells Details
    • 7.7.2 Cells for Cells Major Business
    • 7.7.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.7.4 Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Cells for Cells Recent Developments/Updates
    • 7.7.6 Cells for Cells Competitive Strengths & Weaknesses
  • 7.8 CellTex Therapeutics
    • 7.8.1 CellTex Therapeutics Details
    • 7.8.2 CellTex Therapeutics Major Business
    • 7.8.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.8.4 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.8.5 CellTex Therapeutics Recent Developments/Updates
    • 7.8.6 CellTex Therapeutics Competitive Strengths & Weaknesses
  • 7.9 UCI Health
    • 7.9.1 UCI Health Details
    • 7.9.2 UCI Health Major Business
    • 7.9.3 UCI Health Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.9.4 UCI Health Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.9.5 UCI Health Recent Developments/Updates
    • 7.9.6 UCI Health Competitive Strengths & Weaknesses
  • 7.10 Magellan
    • 7.10.1 Magellan Details
    • 7.10.2 Magellan Major Business
    • 7.10.3 Magellan Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.10.4 Magellan Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Magellan Recent Developments/Updates
    • 7.10.6 Magellan Competitive Strengths & Weaknesses
  • 7.11 AbelZeta Pharma
    • 7.11.1 AbelZeta Pharma Details
    • 7.11.2 AbelZeta Pharma Major Business
    • 7.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product and Services
    • 7.11.4 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Revenue, Gross Margin and Market Share (2021-2026)
    • 7.11.5 AbelZeta Pharma Recent Developments/Updates
    • 7.11.6 AbelZeta Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Stem Cell Therapy for Osteoarthritis Industry Chain
  • 8.2 Stem Cell Therapy for Osteoarthritis Upstream Analysis
  • 8.3 Stem Cell Therapy for Osteoarthritis Midstream Analysis
  • 8.4 Stem Cell Therapy for Osteoarthritis Downstream Analysis

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    The global Stem Cell Therapy for Osteoarthritis market size is expected to reach $ 324 million by 2032, rising at a market growth of 29.2% CAGR during the forecast period (2026-2032).
    OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.
    Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
    The key players of Stem Cell Therapy for Osteoarthritis include Medipost, Theracell Advanced Biotechnology, Nature Cell and Stempeutics. The top 2 manufacturers hold approximately 84% of the global market share.
    In terms of product type, Fat Cell is the largest segment, with a share of 94%. And in terms of application, Primary Osteoarthritis has a share about 91 percent.
    This report studies the global Stem Cell Therapy for Osteoarthritis demand, key companies, and key regions.
    This report is a detailed and comprehensive analysis of the world market for Stem Cell Therapy for Osteoarthritis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Stem Cell Therapy for Osteoarthritis that contribute to its increasing demand across many markets.
    Highlights and key features of the study
    Global Stem Cell Therapy for Osteoarthritis total market, 2021-2032, (USD Million)
    Global Stem Cell Therapy for Osteoarthritis total market by region & country, CAGR, 2021-2032, (USD Million)
    U.S. VS China: Stem Cell Therapy for Osteoarthritis total market, key domestic companies, and share, (USD Million)
    Global Stem Cell Therapy for Osteoarthritis revenue by player, revenue and market share 2021-2026, (USD Million)
    Global Stem Cell Therapy for Osteoarthritis total market by Type, CAGR, 2021-2032, (USD Million)
    Global Stem Cell Therapy for Osteoarthritis total market by Application, CAGR, 2021-2032, (USD Million)
    This report profiles major players in the global Stem Cell Therapy for Osteoarthritis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medipost, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Regeneus, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Stem Cell Therapy for Osteoarthritis market
    Detailed Segmentation:
    Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
    Global Stem Cell Therapy for Osteoarthritis Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World
    Global Stem Cell Therapy for Osteoarthritis Market, Segmentation by Type:
    Fat Cell
    Bone Marrow Cell
    Others
    Global Stem Cell Therapy for Osteoarthritis Market, Segmentation by Application:
    Primary Osteoarthritis
    Secondary Osteoarthritis
    Companies Profiled:
    Medipost
    Theracell Advanced Biotechnology
    Nature Cell
    Stempeutics
    Regeneus
    Xintela AB
    Cells for Cells
    CellTex Therapeutics
    UCI Health
    Magellan
    AbelZeta Pharma
    Key Questions Answered
    1. How big is the global Stem Cell Therapy for Osteoarthritis market?
    2. What is the demand of the global Stem Cell Therapy for Osteoarthritis market?
    3. What is the year over year growth of the global Stem Cell Therapy for Osteoarthritis market?
    4. What is the total value of the global Stem Cell Therapy for Osteoarthritis market?
    5. Who are the Major Players in the global Stem Cell Therapy for Osteoarthritis market?
    6. What are the growth factors driving the market demand?

    Buy now